弘陽地產(01996.HK)遭提清盤呈請 涉至少2.29億美元財務義務
弘陽地產(01996.HK)公佈,紐約梅隆銀行倫敦分行向香港高等法院提呈針對公司的清盤呈請,涉及金額不少於2.29億美元的財務義務,即公司所發行於去年到期的2億美元9.5釐有擔保票據項下的付款金額。
公司正就有關對該呈請的適當迴應尋求法律意見。目前,有關該呈請尚未進行聆訊,且高等法院尚未對公司發出清盤令。
此外,公司已與持有大量優先票據(包括公司所發行的其他有擔保票據)的若幹持有人保持持續溝通,並始終認爲,基於各方一致意見的重組乃爲所有持份者保存價值的最佳方法,因此符合所有持份者的最佳利益。公司仍致力於與其債權人溝通,以探索所有可行的選擇,從而尋求針對當前情況的全面解決方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.